Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00584857 · ClinicalTrials.gov registry record · Phase 2

A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer

A Phase 2 study of Uterine Cancer, sponsored by University of Alabama at Birmingham.

Completed
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT00584857 is a Phase 2 study of Uterine Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 270-participant average among 27 other Uterine Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00584857, a Phase 2 study of Uterine Cancer, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a study to determine the optimal treatment for patients with advanced stage or recurrent endometrial cancer. Traditionally, patients have been treated with either hormonal therapies (megesterol) or chemotherapy (paclitaxel and carboplatin). This study investigates the effectiveness of the combination of hormonal therapy and chemotherapy. This study also will examine the side-effects associated with these drugs and the quality of life of patients on combination therapy.

Conditions Studied

Uterine Cancer

Interventions

  • DRUG Paclitaxel ,Carboplatin , Megesterol Acetate

Study Locations (1)

Alabama

  • UAB Women's and Infant Center, 1700 6th Ave S - Birmingham

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2004-07
Est. Completion 2011-10
Phase Phase 2

Sponsor

University of Alabama at Birmingham

1,160 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00584857

The ClinicalTrials.gov registry entry for NCT00584857 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 270-participant average among 27 other Uterine Cancer trials with a reported enrollment target (89% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Uterine Cancer appearing as the primary indexed condition, and to 1 intervention - of which Paclitaxel ,Carboplatin , Megesterol Acetate is the first listed.

NCT00584857 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT00584857 about?

NCT00584857 is a clinical study titled "A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer". This is a study to determine the optimal treatment for patients with advanced stage or recurrent endometrial cancer. Traditionally, patients have been treated with either hormonal therapies (megesterol) or chemotherapy (paclitaxel and carboplatin). This study investigates the effectiveness of the co...

What is the current status of trial NCT00584857?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2004-07. Estimated completion is 2011-10.

What conditions does trial NCT00584857 study?

This clinical trial studies the following conditions: Uterine Cancer.

What interventions are being tested in trial NCT00584857?

The interventions under investigation include: Paclitaxel ,Carboplatin , Megesterol Acetate (DRUG).

Who is sponsoring clinical trial NCT00584857?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00584857 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Uterine Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Uterine Cancer

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.